Precision LBx Summit

Memo

The 3rd Annual Precision LBx Summit will bring together pharmaceutical, biotech, academic and clinical leaders to provide a platform to advance the validation, clinical utility and industry applications of liquid biopsies. Showcasing robust data-lead studies and trials, the meeting will tackle challenges in technology, standardization and sensitivity of tests. Exploring a multitude of biomarkers from CTCs and ctDNA to RNA and exosomes, Precision LBx 2019 will advance the industry applications of liquid biopsies for oncology and chronic disease through CSF, urine and plasma-derived biomarkers. As the dedicated scientific and networking forum of liquid biopsy trailblazers, the meeting is here to help precision medicine leaders radically improve the analysis and clinical utility of liquid biopsies as clinical monitoring tools. http://lbx-summit.com/ Contact:This email address is being protected from spambots. You need JavaScript enabled to view it.+ 1 415 735 3289 URLs:Brochure: https://go.evvnt.com/304868-0?pid=5569  Tickets: https://go.evvnt.com/304868-1?pid=5569  Time: 08:00 to 16:00. Venue details: DoubleTree by Hilton Hotel San Diego - Mission Valley, 7450 Hazard Center Drive, San Diego, 92108, United States. Prices: Academic, Hospital and Drug Developer Earlybird Conference (Book by 16/11/18): USD 799.0,Academic, Hospital and Drug Developer Conference Only (standard rate): USD 1299.0,Service Provider Earlybird Conference (Book by 16/11/18): USD 2399.0,Service Provider Conference Only (standard rate): USD 3299.0. Speakers: Razelle Kurzrock (UCSD), Dennis Merkle (EMD Serono), Danielle Murphy (Pfizer), Joshua Xu (FDA), Stuart Martin (University of Maryland School of Medicine, Greenebaum Comprehensive Cancer Center)